Interim Chief, Rad Oncology Radiology, Massachusetts General Hospital

Jenot W. and William U. Shipley Professor of Radiation Oncology Harvard Medical School

Radiation Oncologist Radiation Oncology, Massachusetts General Hospital

MD University of London, School of Medicine/University College 1983

active surveillance; adenocarcinoma; bladder cancer; brachytherapy; carcinoma transitional cell; cystectomy; hormone therapy; prostate cancer; prostate-specific antigen; prostatic neoplasms; proton beam therapy; radiation oncology; urinary bladder neoplasms Dr Zietman received his undergraduate training at Oxford University in the UK and then went to medical school at the Middlesex Hospital, London University graduating in 1983. After residencies in internal medicine and clinical oncology he moved to the Massachusetts General Hospital in Boston, USA for a fellowship in radiation biology. Since joining the staff he has authored over 100 original articles and reviews on many aspects of GU cancer. His particular research interests are in the specific roles of active surveillance, brachytherapy, hormone therapy, and proton beam therapy in the treatment of prostate cancer. He also has a long-standing interest in the organ-sparing management of bladder cancer. He is currently the Jenot and William Shipley Professor of Radiation Oncology at Harvard Medical School, President of the American Society for Radiation Oncology (ASTRO), and a trustee of the American Board of Radiology.